Learn how a staple from our medicine cabinet has the potential to support the immune system in combating metastatic cancer.

After analyzing the data, the researchers found that people who took aspirin were 26% more likely to develop heart failure ...

New research in mice may explain why aspirin seems to lower the risk of people's cancers spreading out of control.

A large trial shows aspirin does not significantly improve disease-free survival in patients with high-risk colorectal cancer ...

New medical guidelines warn that aspirin is not always safe for older adults. The biggest risk is bleeding, especially in the ...

An investigation is under way after a mistake means people might be taking incorrect medication which could be 'dangerous' ...

The University of Cambridge has discovered that aspirin may help the immune system recognize and kill metastasizing cancer cells. This finding suggests aspirin could become a valuable ally in cancer ...

Research spanning 30 years shows taking aspirin twice weekly reduces colorectal cancer risk by 18%, with greater benefits for ...

Daily aspirin use after standard adjuvant therapy did not improve DFS for patients with colorectal cancer, according to ...

Holdings rovided an update on its two patent applications, originally filed as provisional patent applications with the ...

HUMACAO, PUERTO RICO AND NEW YORK, NY / ACCESS Newswire / March 13, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or ...